MedBright AI Announces Beta Customer for MedMatrix, the AI-Driven Data and Analytics Platform

MedBright AI Investments Inc. is pleased to announce that the Dermatology Institute & Skin Care Center, a leader in dermatologic services in Southern California, has chosen to implement MedMatrix to improve their clinic operations. MedMatrix is an industry leading AI-powered data analytics platform developed and operated by Healthcare Accretion AI, a Medbright AI investment. MedMatrix harnesses the power of artificial intelligence to evaluate and analyze key aspects of healthcare facilities, including patient needs and resource matching, revenue cycle management, patient demographics, facility geography, and competition. Through its advanced AI and data analytics capabilities, MedMatrix works alongside healthcare professionals to optimize each of these critical areas, resulting in more efficient clinic operations and improved patient outcomes.

Recommended AI News: Riding on the Generative AI Hype, CDP Needs a New Definition in 2024

Recommended AI News: New Research from ASUG Identifies Custom Code as the Top Challenge for Large-Scale ERP Migrations

DISCC specializes in cosmetic, medical, and surgical dermatology in Los Angeles. Led by board-certified dermatologist Paul Yamauchi, MD, PhD, the practice offers state-of-the-art dermatology services to provide the highest quality skin care possible. Dr. Yamauchi is a nationally recognized dermatologist and a key opinion leader in the subject of psoriatic, atopic dermatitis and other inflammatory skin disorders. In addition to his role as medical director for DISCC, he is also the medical director for Clinical Science Institute, the clinical assistant professor of dermatology for the David Geffen School of Medicine and an adjunct associate professor of the John Wayne Cancer Institute.

“There is clearly a need for AI to help operations and the efficiency of clinics,” Dr. Yamauchi said. “I’m excited to see the improvements we can make as a result of using the MedMatrix platform.”

Recommended AI News: Blueshift Launches Free CDP Starter For Cross-Channel Engagement

Michael Dalsin, Chairman of Healthcare Accretion AI, said “We are pleased to have DISCC and Dr. Yamauchi as customers of the MedMatrix Platform, and are looking forward to showing the results of our early operations with DISCC in the coming months.”

[To share your insights with us, please write to sghosh@martechseries.com]